Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01608490 · ClinicalTrials.gov registry record · NA
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
A NA study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 315
- Enrollment target
NCT01608490 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 315 participants.
The verdict
NCT01608490, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
Study Summary
Multicenter, randomized, assessor-blinded controlled study of safety and effectiveness of the PneumRx, Inc. RePneu Lung Volume Reduction Coil (RePneu LVRC) System
Interventions
- DEVICE RePneu Lung Volume Reduction Coil System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01608490
The ClinicalTrials.gov registry entry for NCT01608490 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RePneu Lung Volume Reduction Coil System is the first listed.
NCT01608490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01608490 about?
NCT01608490 is a clinical study titled "Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study". Multicenter, randomized, assessor-blinded controlled study of safety and effectiveness of the PneumRx, Inc. RePneu Lung Volume Reduction Coil (RePneu LVRC) System
What is the current status of trial NCT01608490?
This trial is currently terminated. It is a NA study. The enrollment target is 315 participants. The study started on 2012-10. Estimated completion is 2019-07-26.
What interventions are being tested in trial NCT01608490?
The interventions under investigation include: RePneu Lung Volume Reduction Coil System (DEVICE).
Who is sponsoring clinical trial NCT01608490?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.